In prostate cancer, Jung et al. reported increased levels of TIMP-1 in the plasma of patients with metastatic disease compared to those of patients with organ-confined cancer or with benign prostatic hyperplasia [26,155]. The gene discussed is TIMP1; the disease is prostate carcinoma.